Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: J Autoimmun. 2019 Dec 4;110:102356. doi: 10.1016/j.jaut.2019.102356

Table 4.

Types of Biomarkers

Antecedent Risk for disease
Screening Subclinical Disease
Diagnostic Overt disease
Staging Disease severity
Monitoring Disease activity
Prognostic Future course
Theranostic Response to therapy